Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Sullivan

Showing results (61-70 of 326) with videos related to

Pageof 33
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Frontline Therapy for <i>BRAF</i>-Mutated Metastatic Melanoma: How Do You Choose, and Is There One Correct Answer?Anna C Pavlick, Leslie Fecher, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2018
Keeping Expectations in Check With Immune Checkpoint InhibitorsJennifer S Temel, Justin F Gainor, Ryan J Sullivan, et al.
Expert Opinion on Investigational Drugs|March 21, 2007
Investigational agents for treatment of AIDS-related Kaposi's sarcomaPanagiotis A Konstantinopoulos, Ryan J Sullivan, Michalis V Karamouzis, et al.
Journal of the American College of Cardiology|August 4, 2018
Reply: Immunosuppression Does Not Reduce Antitumor EfficacySyed S Mahmood, Ryan J Sullivan, Kerry L Reynolds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2008
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman diseaseRyan J Sullivan, Liron Pantanowitz, Corey Casper, et al.
Frontiers in Pharmacology|February 23, 2023
Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume IIChuqi Lei, Xiangyi Kong, Ryan J Sullivan, et al.
The Oncologist|October 26, 2020
Emerging Immunotherapies in the Treatment of Brain MetastasesEdwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, et al.
The American Journal of the Medical Sciences|November 22, 2007
Multicentric Castleman's disease masquerading as HIV-related lymphomaFarshid Dayyani, Liron Pantanowitz, Tom G Sandridge, et al.
Canadian Respiratory Journal|August 22, 2008
Residual hemothorax after chest tube placement correlates with increased risk of empyema following traumatic injuryRiyad Karmy-Jones, Michele Holevar, Ryan J Sullivan, et al.
The AIDS Reader|May 30, 2007
Images in HIV/AIDS. Pericardial primary effusion lymphomaJulia M Braza, Ryan J Sullivan, Parul Bhargava, et al.
Pageof 33

Showing results (61-70 of 326) with videos related to

Sort By:
Pageof 33
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Frontline Therapy for <i>BRAF</i>-Mutated Metastatic Melanoma: How Do You Choose, and Is There One Correct Answer?Anna C Pavlick, Leslie Fecher, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2018
Keeping Expectations in Check With Immune Checkpoint InhibitorsJennifer S Temel, Justin F Gainor, Ryan J Sullivan, et al.
Expert Opinion on Investigational Drugs|March 21, 2007
Investigational agents for treatment of AIDS-related Kaposi's sarcomaPanagiotis A Konstantinopoulos, Ryan J Sullivan, Michalis V Karamouzis, et al.
Journal of the American College of Cardiology|August 4, 2018
Reply: Immunosuppression Does Not Reduce Antitumor EfficacySyed S Mahmood, Ryan J Sullivan, Kerry L Reynolds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2008
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman diseaseRyan J Sullivan, Liron Pantanowitz, Corey Casper, et al.
Frontiers in Pharmacology|February 23, 2023
Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume IIChuqi Lei, Xiangyi Kong, Ryan J Sullivan, et al.
The Oncologist|October 26, 2020
Emerging Immunotherapies in the Treatment of Brain MetastasesEdwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, et al.
The American Journal of the Medical Sciences|November 22, 2007
Multicentric Castleman's disease masquerading as HIV-related lymphomaFarshid Dayyani, Liron Pantanowitz, Tom G Sandridge, et al.
Canadian Respiratory Journal|August 22, 2008
Residual hemothorax after chest tube placement correlates with increased risk of empyema following traumatic injuryRiyad Karmy-Jones, Michele Holevar, Ryan J Sullivan, et al.
The AIDS Reader|May 30, 2007
Images in HIV/AIDS. Pericardial primary effusion lymphomaJulia M Braza, Ryan J Sullivan, Parul Bhargava, et al.
Pageof 33